MXD3 Promotes Obesity and the Androgen Receptor Signaling Pathway in Gender-Disparity Hepatocarcinogenesis
Open Access
Abstract
Obesity is closely linked to metabolic diseases, particularly non-alcoholic steatohepatitis (NASH) or non-alcoholic fatty liver disease (NAFLD), ultimately leading to hepatocellular carcinoma (HCC). However, the molecular mechanisms of NASH-associated HCC (NAHCC) remain elusive. To explore the impact of Max dimerization protein 3 (MXD3), a transcription factor that regulates several cellular functions in disorders associated with metabolic diseases, we conditionally expressed Mxd3 proteins using Tet-on mxd3 transgenic zebrafish (MXs) with doxycycline (MXs + Dox) or without doxycycline (MXs − Dox) treatment. Overexpression of global MXD3 (gMX) or hepatic Mxd3 (hMX) was associated with obesity-related NAFLD pathophysiology in gMX + Dox, and liver fibrosis and HCC in hMX + Dox. Oil Red O (ORO)-stained signals were seen in intravascular blood vessels and liver buds of larval gMX + Dox, indicating that Mxd3 functionally promotes lipogenesis. The gMX + Dox-treated young adults exhibited an increase in body weight and visceral fat accumulation. The hMX + Dox-treated young adults showed normal body characteristics but exhibited liver steatosis and NASH-like phenotypes. Subsequently, steatohepatitis, liver fibrosis, and NAHCC were found in 6-month-old gMX + Dox adults compared with gMX − Dox adults at the same stage. Overexpression of Mxd3 also enhanced AR expression accompanied by the increase of AR-signaling pathways resulting in hepatocarcinogenesis in males. Our results demonstrate that global actions of Mxd3 are central to the initiation of obesity in the gMX zebrafish through their effects on adipogenesis and that MXD3 could serve as a therapeutic target for obesity-associated liver diseases.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST 108-2313-B-010-001-MY3)
- Keelung Chang Gung Memorial Hospital (CMRPG2I0071, CMRPG2I0072, and CMRPG2I0073)
- Far Eastern Memorial Hospital (110DN03)
This publication has 69 references indexed in Scilit:
- Development of an Assay for High-Throughput Energy Expenditure Monitoring in the ZebrafishZebrafish, 2013
- Role of MXD3 in Proliferation of DAOY Human Medulloblastoma CellsPLOS ONE, 2012
- Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohortInternational Journal of Cancer, 2012
- Overexpression of Akt1 Enhances Adipogenesis and Leads to Lipoma Formation in ZebrafishPLOS ONE, 2012
- Mad3 Negatively Regulates B Cell Differentiation in the Spleen by Inducing Id2 ExpressionMolecular Biology of the Cell, 2010
- A Novel Role of the Mad Family Member Mad3 in Cerebellar Granule Neuron Precursor ProliferationMolecular and Cellular Biology, 2007
- Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studiesBritish Journal of Cancer, 2007
- Adiponectin and cancer: a systematic reviewBritish Journal of Cancer, 2006
- Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro.Journal of Cell Biology, 1995
- Myc—Max—Mad: a transcription factor network controlling cell cycle progression, differentiation and deathCurrent Opinion in Genetics & Development, 1994